QA: Effector Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001828522_2022_Effector_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001828522, Effector Therapeutics Inc

  xvar xval
0 AssetsCurrent 52,896,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 91,000
3 remainder_Assets 1,069,000
4 LiabilitiesCurrent 3,978,000
5 LiabilitiesNoncurrent 126,000
6 remainder_Liabilities 32,668,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,371,000
9 ResearchAndDevelopmentExpense 19,956,000
10 remainder_Expenses 0
11 remainder_Revenues 1,430,000
12 remainder_NetIncome 47,695,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 54,056,000
1 Liabilities 36,772,000
2 Expenses 33,327,000
3 Revenues 1,430,000
4 StockholdersEquity 17,284,000
5 NetIncome 15,798,000
6 ComprehensiveNetIncome 15,798,000
7 BaseVar 86,640,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.18
9 EconomicCapitalRatio 2.44

Edgar->Model Mapping

Feature Distribution